Novo investors call for dealmaking and new drugs
Ozempic maker is under pressure to diversify as it prepares to face shareholders on Monday
We haven't written up this one. Financial Times has the full story — the link below goes straight to it.
What's breaking now, across thousands of outlets.
Ozempic maker is under pressure to diversify as it prepares to face shareholders on Monday
We haven't written up this one. Financial Times has the full story — the link below goes straight to it.
Governments need to start planning for the long term again
Supplies racing to hit emissions targets push cost to record low, in move that could accelerate industry’s shift to greener fuels
Kingdom’s central bank withdrew last year from programme which is part of China’s effort to develop an alternative system to the dollar
Ten NSE midcap stocks recorded their highest quarterly net profits in the June 2026 quarter, with each surpassing its previous peak over the past 10 quarters, according to StockEdge’s profitability…
The 2-year and 3-year yields indicate that the 10-year yield could go way higher over the next few months.